Citation Impact
Citing Papers
Effect of Niclosamide on Basal-like Breast Cancers
2014
Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma
2005 Standout
Circulating microRNAs as stable blood-based markers for cancer detection
2008 Standout
Synergistic Antitumor Effects of Combined Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor-2 Targeted Therapy
2006
TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth
2007
Receptor-Binding, Biodistribution, and Metabolism Studies of 64 Cu-DOTA-Cetuximab, a PET-Imaging Agent for Epidermal Growth-Factor Receptor-Positive Tumors
2008
Molecular targeting therapy for pancreatic cancer
2004
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Prenatal Bisphenol A exposure delays the development of the male rat mammary gland
2014
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Systemic effects of local radiotherapy
2009
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
The male mammary gland: A target for the xenoestrogen bisphenol A
2013
Targeting hypoxia in cancer therapy
2011 Standout
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Management of borderline and locally advanced pancreatic cancer: Where do we stand?
2014
Bisphenol A and human health: A review of the literature
2013 Standout
Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer
2004
Targeting death-inducing receptors in cancer therapy
2007
Estrogens in the wrong place at the wrong time: Fetal BPA exposure and mammary cancer
2014
Endocrine Disruptors and the Breast: Early Life Effects and Later Life Disease
2013
Proteomic analysis in mammary glands of rat offspring exposed in utero to bisphenol A
2010
The effect of dietary zinc - and polyphenols intake on DMBA-induced mammary tumorigenesis in rats
2012
Quantitative Assessment of Mammary Gland Development in Female Long Evans Rats Following In Utero Exposure to Atrazine
2010
Self-assembled nanospheres as a novel delivery system for taxol: a molecular hydrogel with nanosphere morphology
2011
The inhibition of tumor growth and metastasis by self-assembled nanofibers of taxol
2012
The HIF-1-active microenvironment: An environmental target for cancer therapy
2009
BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas
2007
Resistance mechanisms to cancer chemotherapy
2008
The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers
2016
Pancreatic cancer
2016 Standout
Smad4 Inhibits Tumor Growth by Inducing Apoptosis in Estrogen Receptor-α-positive Breast Cancer Cells
2005
Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice
2008
In utero exposure to butyl benzyl phthalate induces modifications in the morphology and the gene expression profile of the mammary gland: an experimental study in rats
2011
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain
2005
Small cell astrocytoma: An aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma
2004
Ultrasonic Fenton-like catalytic degradation of bisphenol A by ferroferric oxide (Fe3O4) nanoparticles prepared from steel pickling waste liquor
2014
The golden age: gold nanoparticles for biomedicine
2011 Standout
Exposure to the endocrine disruptor bisphenol A alters susceptibility for mammary cancer
2011
Anaplastic Oligodendroglioma and Oligoastrocytoma
2007
Environmental causes of cancer: endocrine disruptors as carcinogens
2010
Interpreting endocrine disruption from an integrative biology perspective
2009
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Malignant Gliomas in Adults
2008 Standout
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Endometriosis
2010 Standout
Chemotherapy Dosing Part I: Scientific Basis for Current Practice and Use of Body Surface Area
2006
Expression and DNA methylation changes in human breast epithelial cells after bisphenol A exposure
2012
Primary brain tumours in adults
2012 Standout
Pancreatic Cancer
2010 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Bisphenol A Increases Mammary Cancer Risk in Two Distinct Mouse Models of Breast Cancer
2011
Clinical targeting of the TNF and TNFR superfamilies
2013
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
2009 Standout
The Hallmarks of Aging
2013 Standout
Perinatal exposure to xenoestrogens impairs mammary gland differentiation and modifies milk composition in Wistar rats
2012
Gold Nanoparticles for Biology and Medicine
2010 Standout
A review of the carcinogenic potential of bisphenol A
2015
Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity
2005
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Prenatal TCDD exposure predisposes for mammary cancer in rats
2006
Modes of resistance to anti-angiogenic therapy
2008 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Tumor Angiogenesis
2008 Standout
Chiral Brønsted acid catalyzed Friedel–Crafts alkylation reactions
2009 Standout
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Combined Toxic Exposures and Human Health: Biomarkers of Exposure and Effect
2011
Inhibition of Src Tyrosine Kinase as Treatment for Human Pancreatic Cancer Growing Orthotopically in Nude Mice
2004
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2
2010
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Bisphenol A alters the development of the rhesus monkey mammary gland
2012
β-Phenylethylamines and the isoquinoline alkaloids
2004
Selective Killing of Hypoxia-Inducible Factor-1–Active Cells Improves Survival in a Mouse Model of Invasive and Metastatic Pancreatic Cancer
2009 StandoutNobel
Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening
2014
Endocrine-Disrupting Chemicals and Public Health Protection: A Statement of Principles from The Endocrine Society
2012
Dynamic Combinatorial Chemistry
2006 Standout
Paclitaxel-Functionalized Gold Nanoparticles
2007
Perinatal Exposure to Bisphenol A Increases Adult Mammary Gland Progesterone Response and Cell Number
2011
Significance of Necrosis in Grading of Oligodendroglial Neoplasms: A Clinicopathologic and Genetic Study of Newly Diagnosed High-Grade Gliomas
2006
Increased Plasma Vascular Endothelial Growth Factor (VEGF) as a Surrogate Marker for Optimal Therapeutic Dosing of VEGF Receptor-2 Monoclonal Antibodies
2004
Targeted delivery of methotrexate to epidermal growth factor receptor–positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates
2006
Functional π-Gelators and Their Applications
2014 Standout
Synthesis of Water-Soluble Dendrimers Based on Melamine Bearing 16 Paclitaxel Groups
2007
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Epigenome scans and cancer genome sequencing converge on WNK2 , a kinase-independent suppressor of cell growth
2007
Proteolysis: A Biological Process Adapted in Drug Delivery, Therapy, and Imaging
2009
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Chronic Oral Exposure to Bisphenol A Results in a Nonmonotonic Dose Response in Mammary Carcinogenesis and Metastasis in MMTV-erbB2 Mice
2011
The 2007 WHO Classification of Tumours of the Central Nervous System
2010 Standout
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial
2004
Thiocolchicine−Podophyllotoxin Conjugates: Dynamic Libraries Based on Disulfide Exchange Reaction
2006
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications
2015
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
2014 Standout
Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors
2010
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Environmental Exposures and Mammary Gland Development: State of the Science, Public Health Implications, and Research Recommendations
2011
Grapes and Human Health: A Perspective
2008
Cross-Dehydrogenative Coupling (CDC): Exploring C−C Bond Formations beyond Functional Group Transformations
2008 Standout
Optical Imaging of Tumor Hypoxia and Evaluation of Efficacy of a Hypoxia-Targeting Drug in Living Animals
2005
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Nitrated Confined Imidodiphosphates Enable a Catalytic Asymmetric Oxa-Pictet–Spengler Reaction
2016 StandoutNobel
Perinatally Administered Bisphenol A as a Potential Mammary Gland Carcinogen in Rats
2013
In Utero Exposure to Bisphenol A Shifts the Window of Susceptibility for Mammary Carcinogenesis in the Rat
2010
Dose translation from animal to human studies revisited
2007 Standout
Works of Mark Carpenter being referenced
Intraperitoneal Radioimmunotherapy with a Humanized Anti-TAG-72 (CC49) Antibody with a Deleted CH2 Region
2005
Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats.
2006
Prognostic Value of 1p, 19q, 9p, 10q, and EGFR-FISH Analyses in Recurrent Oligodendrogliomas
2004
Adenovirus-Mediated Transfer of BAX Driven by the Vascular Endothelial Growth Factor Promoter Induces Apoptosis in Lung Cancer Cells
2002
Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation
2002
Phase I Study of Capecitabine With Concomitant Radiotherapy for Patients With Locally Advanced Pancreatic Cancer: Expression Analysis of Genes Related to Outcome
2005
Fetal and Maternal Effects of Phenylephrine and Ephedrine during Spinal Anesthesia for Cesarean Delivery
2002
A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma.
2003
Intraperitoneal Pretarget Radioimmunotherapy with CC49 Fusion Protein
2005
Synthesis and Biological Evaluation of Paclitaxel−C225 Conjugate as a Model for Targeted Drug Delivery1
2003
Antitumor Efficacy of Capecitabine and Celecoxib in Irradiated and Lead-Shielded, Contralateral Human BxPC-3 Pancreatic Cancer Xenografts: Clinical Implications of Abscopal Effects
2005
Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model.
2003
Modeling Biological Variability in 2-D Gel Proteomic Carcinogenesis Experiments
2005
Rapid Identification of Dihydropyrimidine Dehydrogenase Deficiency by Using a Novel 2-13C-Uracil Breath Test
2004
Oral Exposure to Bisphenol A Increases Dimethylbenzanthracene-Induced Mammary Cancer in Rats
2009
Site-Specifically Traced Drug Release and Biodistribution of a Paclitaxel−Antibody Conjugate toward Improvement of the Linker Structure1
2004